Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD309—464m (Dealroom.co estimates Apr 2007.)
Malvern Iowa (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$6.0m | Series A | ||
$30.0m | Series B | ||
$50.0m | Series C | ||
N/A | $1.8m | Debt | |
Total Funding | AUD133m |